Help us learn more about COPD! We want to better understand how your body responds to the nasal flu vaccine and its relation to COPD. We are looking for people with COPD and healthy volunteers for this study. Compensation provided.

Do you have COPD or want to help us understand COPD? If so, you may be able to take part in a research study. We want to learn more about how nose inflammation is related to COPD. We are looking for people with COPD and healthy volunteers for this study. Compensation provided.

Asthma education is very important for patients with asthma to manage their disease. In this study, we are testing an asthma education website to learn if it can improve asthma knowledge.

Are you a healthy person? Have you wanted to get involved in clinical research in lung diseases? If so, you can join our registry list of interested individuals through a quick online form. We will give you a call if there are studies that you may be eligible for.

This study will look at how adultd with severe asthma are managed and how asthma affects their well-being.

Do you have COPD and repeated breathing flares ending up in the hospital? If you are under the care of a doctor at UNC, you may be eligible for a research study to find out which of two medicines, roflumilast or azithromycin, can help your COPD control.

The purpose of this study is to measure the strength of breaths in patients with COPD using a device that mimics different inhalers.

Researchers are looking for current and former smokers with or without COPD to enroll in a registry to be contacted for future studies.

To collect research samples from CF patients already having a clinically indicated colonoscopy. We're collecting a few additional samples on top of what is collected for clinical purposes to give to researchers for future projects. This will increase your time of procedure around 5 minutes.

This is an open-label long-term follow-up study to evaluate the long-term safety and tolerability of sotatercept when added to background PAH therapy in adult participants with PAH. Patients can be considered for entry into the study if they are coming from a parent study using sotatercept (HYPERION).